Affordable Access

Publisher Website

Photochemotherapy improves chronic cutaneous graft-versus-host disease

Authors
Journal
Journal of the American Academy of Dermatology
0190-9622
Publisher
Elsevier
Publication Date
Volume
23
Issue
2
Identifiers
DOI: 10.1016/0190-9622(90)70202-s
Disciplines
  • Medicine

Abstract

We have used oral psoralen photochemotherapy (PUVA) to treat four patients with chronic graft-versus-host disease of the skin, oral mucosa, and liver, who had responded only partially to long-term immunosuppressive therapy (prednisolone, cyclosporine, azathioprine). PUVA therapy was delivered to the entire skin but not to the oral mucosa, and immunosuppressive therapy was continued in all patients. Two patients' skin lesions improved considerably; the oral lesions healed and did not recur in one. Immunosuppressive therapy could be reduced in these two patients. One patient with sicca signs did not improve. One patient had to interrupt PUVA therapy because of side effects attributed to 8-methoxypsoralen (nausea and vomiting). No flare of acute cutaneous graft-versus-host disease was noted during PUVA therapy. Chronic graft-versus-host disease of the liver did not improve in any patient.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Photochemotherapy improves chronic cutaneous graft...

on Journal of the American Academ... August 1990

Two cases of cutaneous chronic graft versus host d...

on Journal of drugs in dermatolog... November 2009

Extracorporeal photochemotherapy as single therapy...

on Transplantation Journal Jan 15, 1995

Chronic cutaneous graft-versus-host disease in man...

on American Journal Of Pathology June 1978
More articles like this..